Votucalis(Akari Therapeutics)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVotucalis(Akari Therapeutics)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionHistamine H3 receptor antagonistsHistamine H1 receptor antagonistsHistamine H2 receptor antagonists +[4] 
TargetsHistamine H4 receptorHistamine H2 receptorHistamine H1 receptor +[4] 
Therapy Area/IndicationsPruritusDermatitis, AtopicNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeak Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeak Bio Inc
Inactive CompaniesN/A
Active IndicationsPruritusDermatitis, AtopicNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A